Serum Soluble Vascular Endothelial Growth Factor Receptor 1 as a Potential Biomarker of Hepatopulmonary Syndrome

BACKGROUND AND AIMS: The results of basic research implicate the vascular endothelial growth factor (VEGF) family as a potential target of hepatopulmonary syndrome (HPS). However, the negative results of anti-angiogenetic therapy in clinical studies have highlighted the need for markers for HPS. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yu-Jie, Wu, Xian-Feng, Wang, Dan-Dan, Li, Peng, Liang, Hao, Hu, Xiao-Yan, Gan, Jia-Qi, Sun, Yi-Zhu, Li, Jun-Hong, Li, Jun, Shu, Xin, Song, Ai-Lin, Yang, Chun-Yong, Yang, Zhi-Yong, Yu, Wei-Feng, Yang, Li-Qun, Wang, Xiao-Bo, Belguise, Karine, Xia, Zheng-Yuan, Yi, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412700/
https://www.ncbi.nlm.nih.gov/pubmed/37577229
http://dx.doi.org/10.14218/JCTH.2022.00421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412700/
https://www.ncbi.nlm.nih.gov/pubmed/37577229
http://dx.doi.org/10.14218/JCTH.2022.00421

Ejemplares similares